US Healthcare Industry Performance Discussed by Aruvian’s R’search in Its New Study Available at MarketPublishers.com
19 Apr 2017 • by Natalie Aster
LONDON – Today, health care in the US is delivered by numerous separate legal entities. The healthcare spending in the country stands at nearly 15% of GDP, the figure is the highest worldwide. The US spends the highest chunk of health care costs on pharmaceuticals globally. Presently, about 85% of the US citizens have health insurance.
The federal government does not provide a guaranteed universal health care to all the citizens, however certain publicly-funded health care programs are available to some of the disabled, elderly and poor. Furthermore, the federal law ensures public access to emergency services ignoring the ability to pay. Citizens without health insurance coverage are likely to pay for medical services. Health insurance in the country is expensive, and medical bills are overwhelmingly the most common reason for personal bankruptcy in the US.
A detailed analysis of the US healthcare industry performance is available in the cutting-edge research report “Healthcare Industry in United States 2017” elaborated by Aruvian’s R’search.
This research publication highlights the prevailing and emerging trends, contains a detailed market analysis, examines the major issues and challenges the industry faces, points out the most lucrative opportunities and covers the hottest issues. The report includes Porter’s five forces analysis, PEST analysis, an insightful overview of the competitive environment with details on top companies. It sheds light on the major drivers and restraints of the country’s healthcare industry, discusses the issue of GPOs in the US healthcare industry and also canvasses the role of IT, amid other important aspects.
To find many other new studies by this publisher visit the Aruvian’s R’search catalogue at MarketPublishers.com.